Search

Search Results

Found 32 items.

In silico studies on modified hydroxamic acid and valporic acid as potential inhibitors for HDAC2

Naresh Kandakatla, Shikha Rathaur, Smruti Sandhya Sahoo, Geetha Ramakrishnan

328-335

2013-07-18
Molecular docking study of active phytocompounds from the methanolic leaf extract of vitex negundo against cyclooxygenase-2

Deepa Murugesan, Renuka Devi Ponnusamy, Dhanalakshmi Karur Gopalan

146-153

2014-03-29
Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity

Krishnakumar Lohidakshan, Manju Rajan, Andhale Ganesh, Mathew Paul, Jithu Jerin

23-29

2018-01-25
Design of 1-(furan-2-yl)-N-(5-substituted phenyl-1, 3, 4-thiadiazol-2-yl) methanimine derivatives as Enoyl-ACP reductase inhibitors: Synthesis, molecular docking studies and antitubercular activity

Bijo Mathew, Githa Elizabeth Mathew, George Sonia, Anila Kumar, Neethu P Charles, Palanisamy Kumar

242-248

2013-05-16
Study of potential xanthine oxidase inhibitors: In silico and in vitro biological activity

Muthuswamy Umamaheswari, Arumugam Madeswaran, Kuppusamy Asokkumar, Thirumalaisamy Sivashanmugam, Varadharajan Subhadradevi, Puliyath Jagannath

117-123

2011-12-17
In silico molecular mechanism of cannabigerol as a cyclooxygenase-2 inhibitor

Muhammad Abdullah Shah, Syed Muhammad Abdullah, Muhammad Azim Khan, Hazrat Amin, . Roohullah

410-413

2013-12-18
Hypoglycemic, hepatoprotective and molecular docking studies of 5-[(4-chlorophenoxy) methyl]-1, 3, 4-oxadiazole-2-thiol

Naureen Shehzadi, Khalid Hussain, Nadeem Irfan Bukhari, Muhammad Islam, Muhammad Tanveer Khan, Muhammad Salman, Sabahat Zahra Siddiqui, Aziz Ur Rehman, Muhammad Athar Abbasi

149-156

2018-05-10
In silico antigenic site evaluation and antiviral therapy against dengue serotypes

Pratap Parida, Priyadarshini Deka, Brajesh Shankar, R. N. S. Yadav

83-95

2014-02-21
A computational approach to analyze the missense mutations in human angiogenin variants leading to amyotrophic lateral sclerosis

K. Sreevishnupriya, Ramalingar Rajasekaran

382-389

2013-11-13
Design, docking, synthesis and anti-E. coli screening of novel thiadiazolo thiourea derivatives as possible inhibitors of Enoyl ACP reductase (FabI) enzyme

Sonia George, Mohammed Basheer Ramzeena, Sayee Vignesh Ram, Senthil Kumar Selvaraj, Shinu Rajan, Thengungal Kochupappy Ravi

49-53

2014-01-31
Homology modeling and docking studies of Plasmodium falciparum telomerase reverse transcriptase with berberine and some of its derivatives

Pratap Parida, Samhita Kalita, R. N. S. Yadav, Brajesh Shankar

96-104

2014-02-25
Design, docking, synthesis and anticancer activity of some novel 2-(4-methylbenzenesulphonamido)pentanedioic acid amide derivatives

Satyajit Dutta, Deepak Kumar, Anand Kumar Mishra, Supratim Ray, K. Nagarajan

328-336

2014-08-01
Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha

Lalit Mohan Nainwal, Pratap Parida, Aparoop Das, Parth Sarathi Bairy

208-217

2014-05-05
In silico analysis of compounds characterized from ethanolic extract of Cucurbita pepo with NF-κB-inhibitory potential

Solomon O. Rotimi, Oluwakemi Anuoluwapo Rotimi, Olawole O. Obembe

551-556

2014-10-26
GABAA receptor binding molecules from Traditional Chinese Medicine: An in silico approach

Meng Lv, Xue Tao Wang, Kun Li, Yue Lan Wang

447-451

2014-09-30
In silico targeting of interleukin-6 by natural compounds

Wei Zhou, Jun-Feng Cai, Feng Yuan, Min Ma, Feng Yin

371-376

2014-08-19
Molecular interactions of an alkaloid euchrestifoline as a new acetylcholinesterase inhibitor

Fazal Ur Rehman, Muhammad Faird Khan, Inamullah Khan, - Roohullah

361-364

2013-10-20
Potential of plant alkaloids as dengue NS3 protease inhibitors: Molecular docking and simulation approach

Muhammad Tahir ul Qamar, Arooj Mumtaz, Usman Ali Ashfaq, Muhammad Muzammal Adeel, Tabeer Fatima

262-267

2014-07-02
Arabinosyl transferase inhibitor design against Mycobacterium tuberculosis using ligand based drug design approach

Bhaskor Kolita, Dhrubajyoti Gogoi, Partha Pratim Dutta, Manobjyoti Bordoloi, Rajib Lochan Bezbaruah

225-229

2014-05-14
Computational analysis of CDH1 missense mutations in the cause of hereditary diffuse gastric cancer

S. Santhiya, V. Shanthi, R. Rajasekaran, Karuppasamy Ramanathan

207-213

2013-05-07
Molecular docking analysis of curcumin analogues as human neutrophil elastase inhibitors

Radhakrishnan Narayanaswamy, Lam Kok Wai, Faridah Abas, Intan Safinar Ismail

77-82

2014-02-19
Virtual screening of compounds derived from Garcinia pedunculata as an inhibitor of gamma hemolysin component A of Staphylococcus aureus

Tarali Chowdhury

67-71

2014-02-13
Molecular docking of viscosine as a new lipoxygenase inhibitor isolated from Dodonaea viscosa

Amir Zada Khan, Akhtar Mohammad, Zafar Iqbal, Itrat Anis, Muhammad Raza Shah, Said Nadeem, Muhammad Rabnawaz, Adnan Shahidullah, Humayun Khan, Inamullah Khan

36-39

2012-12-30
Molecular docking of citrus flavonoids with some targets related to diabetes

Wei Shen, Yan-Hua Lu

156-170

2013-04-19
Molecular docking of taraxerol acetate as a new COX inhibitor

Ubaid Ur Rehman, Jasmin Shah, Mudasser Ahmed Khan, Muhammad Raza Shah, - Ishtiaq, Inamullah Khan

194-197

2013-05-02

1 - 25 of 32 items 1 2 > >>